Biofortuna
Liverpool · Founded 2008
About Biofortuna
Biofortuna provides molecular diagnostics services. It manufactures HLA and ABO genotyping product families for the transplantation and haematology markets. The company is also developing antibody screening, genotyping and phenotyping products, software for genotyping applications, transplant monitoring, and platforms for clinical laboratories, research centers and point-of-care customers. In addition, Biofortuna Ltd. provides genotyping and custom assay development services. The company was incorporated in 2008 and is based in Liverpool, the United Kingdom.
Company Facts
- Founded: 2008
- Legal name: Biofortuna Limited
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $6.9M
- Last round: Series Unknown (Apr 2012)
- Website: biofortuna.com
- Phone: +44 15 1334 0182
Social Profiles
Canonical: https://fsome.com/organization/biofortuna-8332669 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.